HRH3 and schizophrenia: The findings that we report, together with existing evidence of lower ACC glutamate levels being associated with impaired cognition, suggest that H3R antagonism in patients with schizophrenia may improve cognitive impairment, which is a feature of the disorder, by increasing glutamate transmission.